Chemotherapy Plus Cetuximab versus Chemotherapy Alone for Patients with KRAS Wild Type Unresectable Liver-Confined Metastases Colorectal Cancer: An Updated Meta-Analysis of RCTs.

about

Chemotherapy plus Panitumumab Versus Chemotherapy plus Bevacizumab in Metastatic Colorectal Cancer: A Meta-analysis.

P2860

Q49785414-98BEFAAC-99D4-45E5-A8E1-CFBA29DA2D9D

P2860

Chemotherapy Plus Cetuximab versus Chemotherapy Alone for Patients with KRAS Wild Type Unresectable Liver-Confined Metastases Colorectal Cancer: An Updated Meta-Analysis of RCTs.

Item

http://www.wikidata.org/entity/Q39123412

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Chemotherapy Plus Cetuximab ve ...... Updated Meta-Analysis of RCTs.

@en

Chemotherapy Plus Cetuximab ve ...... Updated Meta-Analysis of RCTs.

@nl

type

Item

label

Chemotherapy Plus Cetuximab ve ...... Updated Meta-Analysis of RCTs.

@en

Chemotherapy Plus Cetuximab ve ...... Updated Meta-Analysis of RCTs.

@nl

prefLabel

Chemotherapy Plus Cetuximab ve ...... Updated Meta-Analysis of RCTs.

@en

Chemotherapy Plus Cetuximab ve ...... Updated Meta-Analysis of RCTs.

@nl

P1476

Chemotherapy Plus Cetuximab ve ...... Updated Meta-Analysis of RCTs

@en

P2093

A Jiao

http://www.w3.org/2001/XMLSchema#string

B C Zhao

http://www.w3.org/2001/XMLSchema#string

B M Chen

http://www.w3.org/2001/XMLSchema#string

G Q Zhang

http://www.w3.org/2001/XMLSchema#string

W Lv

http://www.w3.org/2001/XMLSchema#string

Y Shi

http://www.w3.org/2001/XMLSchema#string

P2860

Therapeutic strategy in unresectable metastatic colorectal cancer: an updated review

Cetuximab for the treatment of colorectal cancer.

Quantifying heterogeneity in a meta-analysis

EGFR antagonists in cancer treatment

Cetuximab plus irinotecan, fluorouracil, and leucovorin as first-line treatment for metastatic colorectal cancer: updated analysis of overall survival according to tumor KRAS and BRAF mutation status

Randomized, phase III trial of panitumumab with infusional fluorouracil, leucovorin, and oxaliplatin (FOLFOX4) versus FOLFOX4 alone as first-line treatment in patients with previously untreated metastatic colorectal cancer: the PRIME study

Genetic and immune factors underlying the efficacy of cetuximab and panitumumab in the treatment of patients with metastatic colorectal cancer.

Addition of cetuximab to oxaliplatin-based first-line combination chemotherapy for treatment of advanced colorectal cancer: results of the randomised phase 3 MRC COIN trial.

Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: a model to predict long-term survival.

Resectability and outcome with anti-EGFR agents in patients with KRAS wild-type colorectal liver-limited metastases: a meta-analysis.

P304

8464905

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2017/8464905

http://www.w3.org/2001/XMLSchema#string

P478

2017

http://www.w3.org/2001/XMLSchema#string

P50

J L Zhang

P577

2017-01-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28167959

http://www.w3.org/2001/XMLSchema#string

P921

colorectal cancer

cetuximab

chemotherapy

P932

5266801

http://www.w3.org/2001/XMLSchema#string

Chemotherapy Plus Cetuximab versus Chemotherapy Alone for Patients with KRAS Wild Type Unresectable Liver-Confined Metastases Colorectal Cancer: An Updated Meta-Analysis of RCTs.

about

P2860

P2860

Chemotherapy Plus Cetuximab versus Chemotherapy Alone for Patients with KRAS Wild Type Unresectable Liver-Confined Metastases Colorectal Cancer: An Updated Meta-Analysis of RCTs.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P50

P577

P698

P921

P932